- Cible Skin plans to accelerate growth across geographies including Europe, China and US
- Verlinvest is an international, family-backed investment firm
- The firm invests in the FMCG, health, consumer technology and lifestyle categories
Verlinvest has acquired a minority stake in Cible Skin, a skincare brand.
This investment will enable Cible Skin to accelerate growth across geographies including Europe, China and the US and supports the development of new products and treatments based on the company’s patented immuno-cosmetic approach, according to a release.
Paris-based Cible Skin provides skincare products including cleansers, serums, and moisturizers and a range of treatments at its flagship clinic in Paris. It generated multi-million dollars sales in China after launching there in March 2023.
“We’re excited to support Cible Skin’s expansion in existing and new markets, and our immediate priority will be to help the business in growing digital, commercial and marketing capabilities, as well as reinforcing its brand, community and organization,” said Cecile Chevallier, principal at Verlinvest.
Verlinvest is an international, family-backed investment firm with offices in Brussels, London, New York, Mumbai and Singapore. It focuses on the FMCG, health, consumer technology and lifestyle categories.
The firm’s consumer-focused portfolio includes Oatly, Tony’s Chocolonely and Remy Cointreau as well as beauty and lifestyle brands Purplle.com and Faceland.
No financial details of the transaction were disclosed.